Yeo Sung Yoon

Yeo Sung Yoon


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2014 in Journal of Medicinal Food
Verified
Journal Article
Closed access
SNSung Min Nam
Sung Min Nam
JCJung Hoon Choi
Jung Hoon Choi
DYDae Young Yoo
Dae Young Yoo
WKWoosuk Kim
Woosuk Kim
HJHyo Young Jung
Hyo Young Jung
IHIn Koo Hwang
In Koo Hwang
Aging is a progressive process, and it may lead to the initiation of neurological diseases. In this study, we investigated the effects of wild Indian Curcuma longa using a Morris water maze paradigm on learning and spatial memory in adult and D-galactose-induced aged mice. In addition, the effects on cell proliferation and neuroblast differentiation were assessed by immunohistochemistry for Ki67 and doublecortin (DCX) respectively. The aging model in mice was induced through the subcutaneous administration of D-galactose (100 mg/kg) for 10 weeks. C. longa (300 mg/kg) or its vehicle (physiological saline) was administered orally to adult and D-galactose-treated mice for the last three weeks before sacrifice. The administration of C. longa significantly shortened the escape latency in both adult and D-galactose-induced aged mice and significantly ameliorated D-galactose-induced reduction of cell proliferation and neuroblast differentiation in the subgranular zone of hippocampal dentate gyrus. In addition, the administration of C. longa significantly increased the levels of phosphorylated CREB and brain-derived neurotrophic factor in the subgranular zone of dentate gyrus. These results indicate that C. longa mitigates D-galactose-induced cognitive impairment, associated with decreased cell proliferation and neuroblast differentiation, by activating CREB signaling in the hippocampal dentate gyrus.

27 January 2014 in Neurological Research
Verified
Journal Article
Closed access
IHIn Koo Hwang
In Koo Hwang
JCJung Hoon Choi
Jung Hoon Choi
SNSung Min Nam
Sung Min Nam
OPOk Kyu Park
Ok Kyu Park
Doo-Yeol YooDoo-Yeol Yoo
Doo-Yeol Yoo
YYYeo Sung Yoon
Yeo Sung Yoon
The majority of immune cells in the brain are comprised of microglia, which undergo morphological changes when activated to remove damaged neurons and infectious agents from the brain tissue. In this study, we investigated the effects of type 2 diabetes on microglial activation and the subsequent secretion of pro-inflammatory cytokines, such as interferon-gamma (IFN-gamma) and interleukin-1beta (IL-1beta), in the hippocampus using Zucker diabetic fatty (ZDF) rats and Zucker lean control (ZLC) rats at various diabetic stages. Zucker lean control and Zucker diabetic fatty rats were sacrificed at 12 (early diabetic stage), 20, or 30 weeks of age (chronic diabetic stage), and the hippocampus was obtained via transcardiac perfusion or dissection for immunohistochemistry and western blot analysis, respectively. Zucker diabetic fatty rats demonstrated significantly higher glucose levels at 12 and 30 weeks of age compared to ZLC rats. Microglia immunoreactive to ionized calcium-binding adapter molecule 1 (Iba-1) had hypertrophied cytoplasm with retracted processes at 30 weeks of age. In contrast, Iba-1-immunoreactive microglia displayed similar morphology in ZDF and ZLC rats at 12 and 20 weeks of age. Similarly, IFN-gamma and IL-1beta protein levels were significantly increased in ZDF rats compared to ZLC rats at 30 weeks of age, but not at 12 and 20 weeks of age. Interleukin-1beta immunoreactivity in the ZDF rats predominantly increased in the dentate gyrus and CA1 region of the hippocampus compared to that of ZLC rats at 30 weeks of age. In addition, IL-1beta immunoreactive structures in ZDF rats at 30 weeks of age were detected near the astrocytes and microglia. These results suggest that chronic diabetes activates microglia and significantly increases pro-inflammatory cytokine levels in the hippocampus.

4 November 2008 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
SYSun Shin Yi
Sun Shin Yi
IHIn Koo Hwang
In Koo Hwang
KYKi-Yeon Yoo
Ki-Yeon Yoo
OPOk Kyu Park
Ok Kyu Park
JYJiatian Yu
Jiatian Yu
YYYeo Sung Yoon
Yeo Sung Yoon

3 December 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SCSeungho Choi
Seungho Choi
JWJong Kyu Woo
Jong Kyu Woo
YJYeong-Su Jang
Yeong-Su Jang
JKJu-Hee Kang
Ju-Hee Kang
Jongik HwangJongik Hwang
Jongik Hwang
SOSeung Hyun Oh
Seung Hyun Oh
The transmembrane nerve injury-induced protein 1 (Ninjurin1 or Ninj1) is involved in progressing inflammatory diseases. In this study, we aimed to investigate a novel function of Ninj1 in pulmonary fibrosis. We found that the expression of Ninj1 in a patient cohort was upregulated in the lung specimens of idiopathic pulmonary fibrosis patients as well as mice with bleomycin-induced pulmonary fibrosis. In addition, the BLM-injected Ninj1 KO mice exhibited a mild fibrotic phenotype, as compared to WT mice. Therefore, we hypothesized that Ninj1 would play an important role in the development of pulmonary fibrosis. We discovered that Ninj1 expression increased in BLM-treated macrophages and alveolar epithelial cells (AECs). Interestingly, macrophages bound to BLM-treated AECs were activated. However, when Ninj1 expression was suppressed in either of AECs or macrophages, contact-dependent activation of macrophages with AECs was diminished. In addition, introduction of recombinant mouse Ninj11–50 to macrophages triggered an inflammatory response, but did not stimulate Ninj1-deficient macrophages. In conclusion, we propose that Ninj1 may contribute to activation of macrophages by enhancing interaction with AECs having elevated Ninj1 expression due to injury-inducing stimuli. Consequently, Ninj1 may be involved in the development of pulmonary fibrosis by enhancing inflammatory response of macrophages.

22 August 2007 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
IHIn Koo Hwang
In Koo Hwang
SYSun Shin Yi
Sun Shin Yi
YKYo Na Kim
Yo Na Kim
IKIl Yong Kim
Il Yong Kim
ILIn Se Lee
In Se Lee
JSJe Kyung Seong
Je Kyung Seong

23 July 2015 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
WKWoosuk Kim
Woosuk Kim
DKDae Won Kim
Dae Won Kim
Dae Young YooDae Young Yoo
Dae Young Yoo
HJHyo Young Jung
Hyo Young Jung
JKJong Whi Kim
Jong Whi Kim
IHIn Koo Hwang
In Koo Hwang
Dendropanax morbifera Léveille has been employed for the treatment of infectious diseases using folk medicine. In this study, we evaluated the antioxidant effects of a leaf extract of Dendropanax morbifera Léveille in the hippocampus of mercury-exposed rats. Seven-week-old Sprague–Dawley rats received a daily intraperitoneal injection of 5 μg/kg dimethylmercury and/or oral Dendropanax morbifera Léveille leaf extract (100 mg/kg) for 4 weeks. Animals were sacrificed 2 h after the last dimethylmercury and/or leaf extract treatment. Mercury levels were measured in homogenates of hippocampal tissue, a brain region that is vulnerable to mercury toxicity. In addition, we measured reactive oxygen species production, lipid peroxidation levels, and antioxidant levels in these hippocampal homogenates. Treatment with Dendropanax morbifera Léveille leaf extract significantly reduced mercury levels in hippocampal homogenates and attenuated the dimethylmercury-induced increase in the production of reactive oxygen species and formation of malondialdehyde. In addition, this leaf extract treatment significantly reversed the dimethylmercury-induced reduction in the hippocampal activities of Cu, Zn-superoxide dismutase, catalase, glutathione peroxidase, and glutathione-S-transferase. These results suggest that a leaf extract of Dendropanax morbifera Léveille had strong antioxidant effects in the hippocampus of mercury-exposed rats.